Five Mainboard IPOs Including Shiprocket and Molbio Hit Indian Primary Market Next Week

The Quick Take

• Five mainboard IPOs — Dhoot Transmission, Molbio Diagnostics, Shiprocket, Behari Lal Engg, Milky Mist — launch in India next week
• Grey market premium signals provide early investor demand indicators before official listing performance is known
• The crowded IPO calendar reflects continued primary market confidence despite secondary market choppiness

India's IPO pipeline remains active with five mainboard offerings scheduled to hit the primary market in the coming week, spanning sectors from automotive components to diagnostics, logistics, engineering, and dairy production. The grey market premium data tracked by Mint provides real-money side bets on listing performance — a metric Indian retail investors use as an informal lead indicator for subscription demand. A busy IPO calendar simultaneously signals promoter confidence in receptive market conditions and tests investor appetite across diverse sectors at a time when broader Indian equity markets remain directionally uncertain.

The five concurrent IPOs represent a diverse sector snapshot of India's growing mid-market corporate ecosystem. Shiprocket, a logistics technology platform, sits at the intersection of e-commerce growth and supply chain infrastructure — themes commanding premium valuations in Indian markets. Molbio Diagnostics taps post-pandemic investor interest in domestic rapid-testing healthcare manufacturing. Dhoot Transmission and Behari Lal Engineering address the automobile components sector benefiting from EV transition tailwinds. Milky Mist enters the organized dairy and food sector, where branded players are rapidly capturing share from unorganized markets.

Forward indicators to watch include subscription rates on opening day — particularly the HNI and QIB portions, which signal institutional conviction — and grey market premium movements as the subscription window closes. The macro variable is FII activity in Indian equity markets: net foreign institutional inflows strengthen demand for primary market offerings, while FII selling tends to dampen listing performance regardless of underlying fundamentals. Any SEBI intervention or DRHP amendment for the named companies before opening would shift market pricing assumptions and suppress retail participation significantly.

Synthesized from 1 source.